9Addison J M D, Matthews D M, et al. 1972. Evidence for active transport of the dipeptide glycylsarcosine by hamster je - junum in vitro[J]. Clin. Sci.,43:907.
10Adibi S A . 1997 . The oligopeptide transporter(Pept1) in human intestine :Biology and function[J], Gastroenterology, 113: 332 - 340.
2Zhang L, Strong JM, Qiu w, et aL Scientific perspectives on drug transporters and their role in drug interactions [J]. Mol Pharm, 2006, 3 (1) : 62-69.
3Gaudana R, Jwala J, Boddu SH, et al. Recent perspectives in ocular drug delivery [J]. Pharm Res, 2009, 26 (5): 1197-1216.
4Agu R, Cowley E, Shao D, et aL Proton-coupled oligopeptide transporter (POT) family expression in human nasal epithelium and their drug transport potential [J]. Mol Pharm, 2011, 8(3): 664-672.
5Launay-Vacher V, Izzedine H, Karie S, et al. Renal tubular drug transporters [J]. Nephron Physiol, 2006, 103 (3) : 97-106.
6Zhang T, Xiang CD, Gale D, et al. Drug transporter and cytochrome P450 mRNA expression in human ocular barriers: implications for ocular drug disposition [J]. Drug Metab Dispos, 2008, 36 (7): 1300-1307.
7Newstead S, Drew D, Cameron AD, et al. Crystal structure of a prokaryotic homologue of the mammalian oligopeptide- proton symporters, PepT1 and PepT2 [J]. EMBO J, 2011, 30 (2) : 417-426.
8Meredith D, Price RA. Molecular modeling of PepTl: towards a structure [J]. JMembr Biol, 2006, 213 (2) : 79-88.
9Links JL, Kulkarni AA, Davies DL, et al. Cysteine scanning of transmembrane domain three of the human dipeptide transporter: implications for substrate transport [J]. J Drug Target, 2007, 15 (3):218-225.
10Xu L, Li Y, Haworth IS, et al. Functional role of the intracellular loop linking transmembrane domains 6 and 7 of the human dipeptide transporter hPEPT1 [J]. J Membr Biol, 2010, 238(1-3) : 43-49.
